All of the following statements about the use of spironolactone in CHF are true except:
Loop diuretics are used to provide rapid symptomatic relief whereas aldosterone antagonists decrease the mortality by reversing myocardial remodelling.
It should be administered in low doses to prevent hyperkalemia
It affords prognostic benefit in severe heart failure over and above that afforded by ACE inhibitors
It helps to overcome the refractoriness to thiazides
It affords rapid symptomatic relief in CHF patients